Squarepoint’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.6K | Buy |
+21,652
| New | +$46.6K | ﹤0.01% | 2612 |
|
|
2024
Q4 | – | Sell |
-49,844
| Closed | -$350K | – | 2737 |
|
|
2024
Q3 | $350K | Sell |
49,844
-59,134
| -54% | -$415K | ﹤0.01% | 1927 |
|
|
2024
Q2 | $748K | Buy |
108,978
+81,808
| +301% | +$561K | ﹤0.01% | 1519 |
|
|
2024
Q1 | $384K | Buy |
27,170
+22,937
| +542% | +$324K | ﹤0.01% | 1807 |
|
|
2023
Q4 | $31.9K | Buy |
+4,233
| New | +$31.9K | ﹤0.01% | 2401 |
|
|
2022
Q1 | – | Sell |
-1,506
| Closed | -$27K | – | 2176 |
|
|
2021
Q4 | $27K | Sell |
1,506
-1,877
| -55% | -$33.7K | ﹤0.01% | 2464 |
|
|
2021
Q3 | $73K | Buy |
3,383
+702
| +26% | +$15.1K | ﹤0.01% | 2063 |
|
|
2021
Q2 | $94K | Buy |
+2,681
| New | +$94K | ﹤0.01% | 2426 |
|
|
2021
Q1 | – | Sell |
-2,582
| Closed | -$280K | – | 2502 |
|
|
2020
Q4 | $280K | Sell |
2,582
-6,622
| -72% | -$718K | ﹤0.01% | 1906 |
|
|
2020
Q3 | $948K | Buy |
+9,204
| New | +$948K | 0.01% | 979 |
|
|
2020
Q1 | – | Sell |
-11,197
| Closed | -$1.29M | – | 1795 |
|
|
2019
Q4 | $1.29M | Sell |
11,197
-8,870
| -44% | -$1.02M | 0.01% | 1157 |
|
|
2019
Q3 | $1.09M | Buy |
20,067
+18,667
| +1,333% | +$1.02M | 0.01% | 1145 |
|
|
2019
Q2 | $166K | Buy |
+1,400
| New | +$166K | ﹤0.01% | 2070 |
|
|
2018
Q2 | – | Sell |
-2,964
| Closed | -$172K | – | 1718 |
|
|
2018
Q1 | $172K | Buy |
+2,964
| New | +$172K | ﹤0.01% | 1514 |
|
|
2017
Q4 | – | Sell |
-3,180
| Closed | -$116K | – | 2042 |
|
|
2017
Q3 | $116K | Buy |
3,180
+2,150
| +209% | +$78.4K | ﹤0.01% | 1479 |
|
|
2017
Q2 | $26K | Sell |
1,030
-24
| -2% | -$606 | ﹤0.01% | 1476 |
|
|
2017
Q1 | $28K | Buy |
+1,054
| New | +$28K | ﹤0.01% | 1458 |
|